Age-related changes in serum levels of insulin-like growth factor-II and its binding proteins correlate with calcaneal bone mineral density among post-menopausal South-Indian women

Clinica Chimica Acta

Volumn 414, Issue , 2012, Pages 281-288

  Sittadjody, Sivanandane ^a,b   Ilangovan, Ramachandran ^b,c   Thangasamy, Thilakavathy ^b   Vignesh, Ramamoorthy C ^b   Veni, Subramanyam ^b   Bertoni, Alain G ^a   Srinivasan, Subramanian ^d   Subramanian, Chinappa ^e   Srinivasan, Narasimhan ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MADRAS   (India)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d Sai Orthocare Clinic   (India)

^e SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Aging; Calcaneal BMD; IGF II; IGFBPs; Menopause; Physical activity

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN;

ADULT; AGING; ARTICLE; BONE DENSITY; CALCANEUS; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; INDIAN; LIFESTYLE; MAJOR CLINICAL STUDY; OCCUPATION; OSSIFICATION; OSTEOLYSIS; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; AGED; BLOOD; CHEMISTRY; CROSS-SECTIONAL STUDY; INDIA; MIDDLE AGED; REFERENCE VALUE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; BONE DENSITY; CALCANEUS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INDIA; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; POSTMENOPAUSE; REFERENCE VALUES; YOUNG ADULT;

EID: 84868326137     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.09.030     Document Type: Article

References (65)

1. de Villiers, T.J., Individualized therapy for osteoporosis prevention and treatment in women under 60. Climacteric 12 (2009), 210–212.
2. Pirro, M., Leli, C., Fabbriciani, G., et al. Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis. Osteoporos Int 21 (2010), 297–306.
3. Harada, S., Rodan, G.A., Control of osteoblast function and regulation of bone mass. Nature 423 (2003), 349–355.
4. Heshmati, H.M., Khosla, S., Robins, S.P., O'Fallon, W.M., Melton, L.J. III, Riggs, B.L., Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res 17 (2002), 172–178.
5. Giustina, A., Mazziotti, G., Canalis, E., Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29 (2008), 535–559.
6. Lips, P., Vitamin D, deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22 (2001), 477–501.
7. Kim, J.G., Shin, C.S., Choi, Y.M., Moon, S.Y., Kim, S.Y., Lee, J.Y., The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. Clin Endocrinol (Oxf) 51 (1999), 301–307.
8. Pfeilschifter, J., Scheidt-Nave, C., Leidig-Bruckner, G., et al. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 81 (1996), 2534–2540.
9. Rucker, D., Ezzat, S., Diamandi, A., Khosravi, J., Hanley, D.A., IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men. Clin Endocrinol (Oxf) 60 (2004), 491–499.
10. Ueland, T., Brixen, K., Mosekilde, L., Mosekilde, L., Flyvbjerg, A., Bollerslev, J., Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. J Clin Endocrinol Metab 88 (2003), 1014–1018.
11. Canalis, E., Insulin like growth factors and the local regulation of bone formation. Bone 14 (1993), 273–276.
12. Conover, C.A., In vitro studies of insulin-like growth factor I and bone. Growth Horm IGF Res 10:Suppl. B (2000), S107–S110.
13. Conover, C.A., Johnstone, E.W., Turner, R.T., et al. Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. Growth Horm IGF Res 12 (2002), 178–183.
14. Ishibe, M., Ishibashi, T., Kaneda, K., Koda, T., Rosier, R.N., Puzas, J.E., Stimulation of bone formation in vivo by insulin-like growth factor-II in rats. Calcif Tissue Int 63 (1998), 36–38.
15. Amin, S., Riggs, B.L., Atkinson, E.J., Oberg, A.L., Melton, L.J. III, Khosla, S., A potentially deleterious role of IGFBP-2 on bone density in aging men and women. J Bone Miner Res 19 (2004), 1075–1083.
16. Kelley, K.M., Oh, Y., Gargosky, S.E., et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28 (1996), 619–637.
17. Centrella, M., McCarthy, T.L., Canalis, E., Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone. Endocrinology 126 (1990), 39–44.
18. Jones, J.I., Clemmons, D.R., Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16 (1995), 3–34.
19. Mohan, S., Baylink, D.J., Autocrine and paracrine aspects of bone metabolism. Growth Genet Horm 6 (2010), 1–9.
20. Rosen, C.J., Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications. Clin Chem 45 (1999), 1384–1390.
21. Zapf, J., Froesch, E.R., Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. Horm Res 24 (1986), 121–130.
22. Boonen, S., Mohan, S., Dequeker, J., et al. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res 14 (1999), 2150–2158.
23. Gillberg, P., Olofsson, H., Mallmin, H., Blum, W.F., Ljunghall, S., Nilsson, A.G., Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 70 (2002), 22–29.
24. Ilangovan, R., Sittadjody, S., Balaganesh, M., et al. Dihydrotestosterone is a determinant of calcaneal bone mineral density in men. J Steroid Biochem Mol Biol 117 (2009), 132–138.
25. Riggs, B.L., Melton, L.J. III, Robb, R.A., et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 23 (2008), 205–214.
26. Shatrugna, V., Kulkarni, B., Kumar, P.A., et al. Relationship between women's occupational work and bone health: a study from India. Br J Nutr 99 (2008), 1310–1315.
27. Prevention and management of Osteoporosis. echnical Report 921, 2003, World Health Organization, Geneva.
28. Andersch, M.A., Szczypinski, A.J., Use of p-nitrophenylphosphate as the substrate in determination of serum acid phosphatase. Am J Clin Pathol 17 (1947), 571–574.
29. Tenniswood, M., Bird, C.E., Clark, A.F., Acid phosphatases: androgen dependent markers of rat prostate. Can J Biochem 54 (1976), 350–357.
30. Tung, S., Iqbal, J., Evolution, aging, and osteoporosis. Ann N Y Acad Sci 1116 (2007), 499–506.
31. Langdahl, B.L., Kassem, M., Moller, M.K., Eriksen, E.F., The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone. Eur J Clin Invest 28 (1998), 176–183.
32. McCarthy, T.L., Centrella, M., Canalis, E., Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 124 (1989), 301–309.
33. Sun, W.L., Chen, L.L., Yan, J., Yu, Z.S., Effects of IGF-II on promoting proliferation and regulating nitric oxide synthase gene expression in mouse osteoblast-like cell. J Zhejiang Univ Sci B 6 (2005), 699–704.
34. Ormarsdottir, S., Ljunggren, O., Mallmin, H., Olofsson, H., Blum, W.F., Loof, L., Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density. Liver 21 (2001), 123–128.
35. Miyamoto, N., Imamura, H., Lumbar bone mineral density and insulin-like growth factor binding protein-3 in Japanese collegiate women. J Health Sci 56 (2010), 397–403.
36. Nindl, B.C., Pierce, J.R., Durkot, M.J., et al. Relationship between growth hormone in vivo bioactivity, the insulin-like growth factor-I system and bone mineral density in young, physically fit men and women. Growth Horm IGF Res 18 (2008), 439–445.
37. Sugimoto, T., Nishiyama, K., Kuribayashi, F., Chihara, K., Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 12 (1997), 1272–1279.
38. Yamaguchi, T., Kanatani, M., Yamauchi, M., et al. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and − 5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Calcif Tissue Int 78 (2006), 18–24.
39. Karasik, D., Rosen, C.J., Hannan, M.T., et al. Insulin-like growth factor binding proteins 4 and 5 and bone mineral density in elderly men and women. Calcif Tissue Int 71 (2002), 323–328.
40. Mohan, S., Baylink, D.J., Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab 80 (1995), 637–647.
41. Mohan, S., Farley, J.R., Baylink, D.J., Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: implications for bone loss with aging. Prog Growth Factor Res 6 (1995), 465–473.
42. Nielsen, F.C., The molecular and cellular biology of insulin-like growth factor II. Prog Growth Factor Res 4 (1992), 257–290.
43. O'Dell, S.D., Day, I.N., Insulin-like growth factor II (IGF-II). Int J Biochem Cell Biol 30 (1998), 767–771.
44. Gray, T.K., Mohan, S., Linkhart, T.A., Baylink, D.J., Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106. Biochem Biophys Res Commun 158 (1989), 407–412.
45. Gambacciani, M., New HRT, options for the treatment of menopausal symptoms and the maintenance of quality of life in postmenopausal women. Endocrine 24 (2004), 231–238.
46. Syed, F.A., Oursler, M.J., Hefferanm, T.E., Peterson, J.M., Riggs, B.L., Khosla, S., Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int 19 (2008), 1323–1330.
47. Kasukawa, Y., Miyakoshi, N., Mohan, S., The anabolic effects of GH/IGF system on bone. Curr Pharm Des 10 (2004), 2577–2592.
48. Woller, M.J., Everson-Binotto, G., Nichols, E., et al. Aging-related changes in release of growth hormone and luteinizing hormone in female rhesus monkeys. J Clin Endocrinol Metab 87 (2002), 5160–5167.
49. Rechler, M.M., Clemmons, D.R., Regulatory actions of insulin-like growth factor-binding proteins. Trends Endocrinol Metab 9 (1998), 176–183.
50. Rajaram, S., Baylink, D.J., Mohan, S., Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18 (1997), 801–831.
51. Govoni, K.E., Baylink, D.J., Mohan, S., The multi-functional role of insulin-like growth factor binding proteins in bone. Pediatr Nephrol 20 (2005), 261–268.
52. Ernst, M., Rodan, G.A., Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127 (1990), 807–814.
53. Firth, S.M., Baxter, R.C., Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23 (2002), 824–854.
54. Amarnani, S., Merriman, H.L., Linkhart, T.A., Baylink, D.J., Mohan, S., Autocrine regulators of MC3T3-E1 cell proliferation. J Bone Miner Res 8 (1993), 157–165.
55. Kiefer, M.C., Schmid, C., Waldvogel, M., et al. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J Biol Chem 267 (1992), 12692–12699.
56. Mohan, S., Nakao, Y., Honda, Y., et al. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270 (1995), 20424–20431.
57. Kanzaki, S., Baxter, R.C., Knutsen, R., Baylink, D.J., Mohan, S., Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions. J Bone Miner Res 10 (1995), 854–858.
58. Lemmey, A.B., Glassford, J., Flick-Smith, H.C., Holly, J.M., Pell, J.M., Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I. J Endocrinol 154 (1997), 319–328.
59. Bunn, R.C., Fowlkes, J.L., Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab 14 (2003), 176–181.
60. Mazerbourg, S., Callebaut, I., Zapf, J., Mohan, S., Overgaard, M., Monget, P., Up date on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo. Growth Horm IGF Res 14 (2004), 71–84.
61. Qin, X., Byun, D., Lau, K.H., Baylink, D.J., Mohan, S., Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. Arch Biochem Biophys 379 (2000), 209–216.
62. Slootweg, M.C., Ohlsson, C., Salles, J.P., de Vries, C.P., Netelenbos, J.C., Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Endocrinology 136 (1995), 4210–4217.
63. Ohlsson, C., Bengtsson, B.A., Isaksson, O.G., Andreassen, T.T., Slootweg, M.C., Growth hormone and bone. Endocr Rev 19 (1998), 55–79.
64. Riggs, B.L., Khosla, S., Melton, L.J. III, Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23 (2002), 279–302.
65. Veldhuis, J.D., Roemmich, J.N., Richmond, E.J., Bowers, C.Y., Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocr Rev 27 (2006), 101–140.